Predictors of Postoperative Hypocalcemia and Hypoparathyroidism Following Thyroidectomy in Hanoi, Vietnam.

IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM
International Journal of Endocrinology and Metabolism Pub Date : 2024-06-26 eCollection Date: 2024-04-01 DOI:10.5812/ijem-146358
Khanh Nam Do, Phuong Thi Duong, Toi Lam Phung, Yen Thi Duong, Giang Truong Hoang, Huong Thi Le
{"title":"Predictors of Postoperative Hypocalcemia and Hypoparathyroidism Following Thyroidectomy in Hanoi, Vietnam.","authors":"Khanh Nam Do, Phuong Thi Duong, Toi Lam Phung, Yen Thi Duong, Giang Truong Hoang, Huong Thi Le","doi":"10.5812/ijem-146358","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hypocalcemia is the most frequent complication of thyroid surgeries. Hypocalcemia is the most common complication following thyroid surgeries and is crucial in managing patients with thyroid cancer.</p><p><strong>Objectives: </strong>This study aimed to describe hypocalcemia after thyroidectomy and evaluate the factors associated with postoperative hypocalcemia.</p><p><strong>Methods: </strong>A cross-sectional study was conducted on 91 patients with thyroid cancer at Hanoi Medical University Hospital. Hypocalcemia was defined as serum calcium levels lower than 2.1 mmol/L, measured 24 hours after surgery.</p><p><strong>Results: </strong>In the postoperative period, 27.5% of the patients exhibited hypocalcemia, with distinct prevalence rates observed between the total thyroidectomy group (47.6%) and the thyroid lobectomy group (10.2%). Concurrently, hypoparathyroidism manifested in 15.4% of the cases. Various factors were identified as contributors to postoperative hypocalcemia, including lymph node metastasis (odds ratio [OR] = 2.6; P < 0.05), total thyroidectomy (OR = 8.0; P < 0.01), diminished parathyroid hormone (PTH) levels (OR = 12.6; P < 0.001), and reduced 25-hydroxyvitamin D3 (25[OH]D3) levels (P < 0.01). Furthermore, multivariate analyses revealed that free thyroxine (FT4) (P = 0.04), 25(OH)D3 (P = 0.037), surgical procedure (P < 0.001), and cancer stage (P < 0.001) independently predicted postoperative hypocalcemia. Notably, our findings underscored a substantial correlation between total thyroidectomy (OR = 21.5, P < 0.001), diminished PTH levels (P < 0.001), and the occurrence of postoperative hypoparathyroidism.</p><p><strong>Conclusions: </strong>The identification of lymph node metastasis, total thyroid surgery, decreased PTH and 25(OH)D3 levels, and albumin concentration are crucial factors in guiding the surgical team to prevent the onset of hypocalcemia.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":"22 2","pages":"e146358"},"PeriodicalIF":2.1000,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11892512/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Endocrinology and Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5812/ijem-146358","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/4/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Hypocalcemia is the most frequent complication of thyroid surgeries. Hypocalcemia is the most common complication following thyroid surgeries and is crucial in managing patients with thyroid cancer.

Objectives: This study aimed to describe hypocalcemia after thyroidectomy and evaluate the factors associated with postoperative hypocalcemia.

Methods: A cross-sectional study was conducted on 91 patients with thyroid cancer at Hanoi Medical University Hospital. Hypocalcemia was defined as serum calcium levels lower than 2.1 mmol/L, measured 24 hours after surgery.

Results: In the postoperative period, 27.5% of the patients exhibited hypocalcemia, with distinct prevalence rates observed between the total thyroidectomy group (47.6%) and the thyroid lobectomy group (10.2%). Concurrently, hypoparathyroidism manifested in 15.4% of the cases. Various factors were identified as contributors to postoperative hypocalcemia, including lymph node metastasis (odds ratio [OR] = 2.6; P < 0.05), total thyroidectomy (OR = 8.0; P < 0.01), diminished parathyroid hormone (PTH) levels (OR = 12.6; P < 0.001), and reduced 25-hydroxyvitamin D3 (25[OH]D3) levels (P < 0.01). Furthermore, multivariate analyses revealed that free thyroxine (FT4) (P = 0.04), 25(OH)D3 (P = 0.037), surgical procedure (P < 0.001), and cancer stage (P < 0.001) independently predicted postoperative hypocalcemia. Notably, our findings underscored a substantial correlation between total thyroidectomy (OR = 21.5, P < 0.001), diminished PTH levels (P < 0.001), and the occurrence of postoperative hypoparathyroidism.

Conclusions: The identification of lymph node metastasis, total thyroid surgery, decreased PTH and 25(OH)D3 levels, and albumin concentration are crucial factors in guiding the surgical team to prevent the onset of hypocalcemia.

越南河内甲状腺切除术后低血钙和甲状旁腺功能减退的预测因素。
背景:低钙血症是甲状腺手术最常见的并发症。低钙血症是甲状腺手术后最常见的并发症,对甲状腺癌患者的治疗至关重要。目的:本研究旨在描述甲状腺切除术后的低钙血症,并评估与术后低钙血症相关的因素。方法:对河内医科大学附属医院的91例甲状腺癌患者进行横断面研究。低钙症定义为术后24小时血钙水平低于2.1 mmol/L。结果:27.5%的患者术后出现低钙血症,其中甲状腺全切除术组(47.6%)和甲状腺小叶切除术组(10.2%)患病率明显不同。同时,15.4%的病例表现为甲状旁腺功能减退。各种因素被确定为术后低钙血症的影响因素,包括淋巴结转移(优势比[OR] = 2.6;P < 0.05),全甲状腺切除术(OR = 8.0;P < 0.01),甲状旁腺激素(PTH)水平降低(OR = 12.6;P < 0.001), 25-羟基维生素D3 (25[OH]D3)水平降低(P < 0.01)。此外,多变量分析显示游离甲状腺素(FT4) (P = 0.04)、25(OH)D3 (P = 0.037)、手术方式(P < 0.001)和癌症分期(P < 0.001)独立预测术后低钙血症。值得注意的是,我们的研究结果强调了全甲状腺切除术(OR = 21.5, P < 0.001)、甲状旁腺激素水平降低(P < 0.001)与术后甲状旁腺功能低下的发生之间的实质性相关性。结论:淋巴结转移的识别、全甲状腺手术、PTH和25(OH)D3水平的降低以及白蛋白浓度是指导手术团队预防低血钙发生的关键因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.10
自引率
4.80%
发文量
0
期刊介绍: The aim of the International Journal of Endocrinology and Metabolism (IJEM) is to increase knowledge, stimulate research in the field of endocrinology, and promote better management of patients with endocrinological disorders. To achieve this goal, the journal publishes original research papers on human, animal and cell culture studies relevant to endocrinology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信